Search Results

Psoriasis vulgaris patient with psoriatic arthritis managed with interleukin-17A inhibitor: Balancing benefits and adverse effects

• Authors : Utama, Wina S.; Lestari, Wahyu; Hajar, Sitti

Subjects: Psoriasis vulgaris; psoriatic arthritis; secukinumab

• Source: Narra J; Vol. 4 No. 1 (2024): April 2024 ; e207; 2807-2618

Record details

Mechanism of Interleukin-17A Regulation of Mesenchymal Stroma/Stem Cell Osteogenic Differentiation

• Authors : Santibanez, Juan F.; Santibanez, Juan F.

Subjects: L-17A; mesenchymal stem cells; osteoblast

• Source: Discovery Medicine

Record details

Interleukin-17A stimulation induces alterations in Microglial microRNA expression profiles

• Authors : Iitani, Yukako; Miki, Rika; Imai, Kenji

Record details

Interleukin-17A stimulation induces alterations in Microglial microRNA expression profiles

• Authors : Iitani, Yukako; Miki, Rika; Imai, Kenji

Subjects: Journal Article; AM

Record details

Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment

• Authors : Gergely, Tamás G.; Kucsera, Dániel; Tóth, Viktória E.

Subjects: cancer immunotherapy; cardio-oncology; cardiotoxicity

• Source: Gergely, T G, Kucsera, D, Tóth, V E, Kovács, T, Sayour, N V, Drobni, Z D, Ruppert, M, Petrovich, B, Ágg, B, Onódi, Z, Fekete, N, Pállinger, É, Buzás, E I, Yousif, L I, Meijers, W C,

Record details

Investigation Activities of Vitamin D, Interleukin-17A, and Alkaline Phosphatase as Biological Markers in Asthma

• Authors : Simanjuntak, James Perdinan; Sakdiah, Siti; Sitanggang, Fardiah Tilawati

Subjects: Asthma; inflammation; vitamin D deficiency

• Source: EKSAKTA: Berkala Ilmiah Bidang MIPA; Vol. 24 No. 02 (2023): Eksakta : Berkala Ilmiah Bidang MIPA (E-ISSN : 2549-7464) ; 154-164; 2549-7464; 1411-3724; 10.24036/eksakta/vol24-iss02

Record details

Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures:A Danish Nationwide Study

• Authors : Loft, Nikolai; Egeberg, Alexander; Isufi, Daniel

Subjects: biologics; IL-17; ixekizumab

• Source: Loft , N , Egeberg , A , Isufi , D , Rasmussen , M K , Bryld , L E , Dam , T N , Ajgeiy , K K , Bertelsen , T & Skov , L 2023 , ' Response to Interleukin-17A Inhibitors

Record details

Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures:A Danish Nationwide Study

• Authors : Loft, Nikolai; Egeberg, Alexander; Isufi, Daniel

Subjects: biologics; IL-17; ixekizumab

• Source: Loft , N , Egeberg , A , Isufi , D , Rasmussen , M K , Bryld , L E , Dam , T N , Ajgeiy , K K , Bertelsen , T & Skov , L 2023 , ' Response to Interleukin-17A Inhibitors

Record details

Interleukin-17A derived from mast cells: evidence for an autoinflammatory loop in hidradenitis suppurativa?

• Authors : Giamarellos-Bourboulis, Evangelos J.

Subjects: scientific_publication_article; Scientific publication - Journal Article

Record details

Sonelokimab Interleukin-17A and -F nanobody Treatment of moderate to severe psoriasis Treatment of hidradenitis suppurativa

• Authors : Yao, Yiqiu; Jorgensen, Astrid-Helene Ravn; Nielsen, Valdemar Wendelboe

Subjects: IL-17; Monoclonal antibody; Nanobody

• Source: Yao , Y , Jorgensen , A-H R , Nielsen , V W , Egeberg , A , Thyssen , J P & Thomsen , S F 2022 , ' Sonelokimab Interleukin-17A and -F nanobody Treatment of moderate to

Record details